Concepedia

Izumi Nishino

IN

Statistics

Publications

4

Citations

63

H-Index

4

Active since

2020

Affiliations

Taisho Pharmaceutical (Japan)(Current)

Izumi Nishino is an author at Taisho Pharmaceutical (Japan) specializing in pharmacology, driving maneuver validation, and medicine.

ORCID

Publications per year

2020–2022

4

Publications

4

Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study

Makoto Kamiya, Helene D. Sabia, Julie Marella et al. · Journal of Psychiatric Research · 2020 · 28 citations · Full text

, , +16

Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance

Mari Iwata, Kunihiro Iwamoto, Iwao Kitajima et al. · Psychopharmacology · 2020 · 15 citations · Full text

, , +12

Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer <sup>11</sup>C-TASP699

Mika Naganawa, Nabeel Nabulsi, David Matuskey et al. · Journal of Nuclear Medicine · 2021 · 10 citations

, , +17

Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials

Yuichi Inoue, Makoto Uchiyama, Hideo Umeuchi et al. · BMC Psychiatry · 2022 · 10 citations · Full text

, , +13

1–4 of 4